Over-expression of chloride intracellular channels (CLICs) 3 and 4 in malignant pleural mesothelioma

V. Tasiopoulou, I. Lempesis, D. Magouliotis, R. Jagirdar, E. Solenov, C. Hatzoglou, P. A. Molyvdas, K. Gourgoulianis, S. Zarogiannis (Larissa, Novosibirsk, Greece)

Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Session: Diagnosis and management of pleural and mediastinal diseases
Session type: Thematic Poster Session
Number: 2927
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Tasiopoulou, I. Lempesis, D. Magouliotis, R. Jagirdar, E. Solenov, C. Hatzoglou, P. A. Molyvdas, K. Gourgoulianis, S. Zarogiannis (Larissa, Novosibirsk, Greece). Over-expression of chloride intracellular channels (CLICs) 3 and 4 in malignant pleural mesothelioma. Eur Respir J 2013; 42: Suppl. 57, 2927

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differential gene expression of two-pore-domain potassium channels in malignant pleural mesothelioma
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013

Effect of asbestos on gene expression of tight junctions components in malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016

beta1 and beta2 adrenergic receptors are significantly under-expressed in malignant pleural mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

Activated KRAS signaling triggers malignant pleural effusion
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015

The role of Epithelial sodium channel (ENaC) in cell proliferation and tunneling nanotube (TnT) formation in benign mesothelial cells and malignant pleural mesothelioma (MPM) cells.
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017

Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: In-vitro study
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015


The role of aquaporin-1 (AQP1) and amiloride sensitive epithelial sodium (ENaC) in cell adhesion of mesothelioma cells is cell and extracellular matrix type dependent
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015

The role of amiloride sensitive epithelial sodium channel (ENaC) in cell migration of mesothelioma cells is dependent on the cell type and the extracellular matrix
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016

Role of tumor derived versican in experimental malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016

Hypertonicity increases apparent water permeability in benign mesothelial cells but differentially regulates it in epithelioid mesothelioma cells depending on the osmotic agent
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Volume quantification of malignant pleural mesothelioma
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


High fluorescence cells in pleural fluid. Association with pleural malignancy
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013


Malignant pleural mesothelioma (MPM) – 5 years of experience
Source: Eur Respir J 2006; 28: Suppl. 50, 91s
Year: 2006

Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016

Survival analysis of pleural malignant mesothelioma (MM) at a single Institution in Liguria, Italy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Tumour marker (TM) CA 19-9 in pleural fluid at patients with malignant and paramalignant pleural effusion (PE)
Source: Eur Respir J 2001; 18: Suppl. 33, 387s
Year: 2001

Malignant mesothelioma vs metastatic carcinoma of pleura: Do pathology and radiology agree?
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013

Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM)
Source: Eur Respir J 2004; 24: Suppl. 48, 81s
Year: 2004

Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015